Testing effectiveness (Phase 2)Active Not RecruitingNCT06961344
What this trial is testing
An Open-label Extension Safety Study of MELAS Patients Who Completed TIS6463-203 (PRIZM)
Who this might be right for
Mitochondrial Encephalopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS Syndrome)
Tisento Therapeutics 44